Free Trial

CERo Therapeutics (CEROW) Competitors

$0.0090 +0.00 (+100.00%)
As of 06/5/2026 02:09 PM Eastern

CEROW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy CERo Therapeutics stock or one of its competitors? MarketBeat compares CERo Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CERo Therapeutics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does CERo Therapeutics compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and CERo Therapeutics (NASDAQ:CEROW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
CERo TherapeuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
CERo Therapeutics N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than CERo Therapeutics. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for CERo Therapeutics. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled CERo Therapeutics'average media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
CERo Therapeutics Neutral

Summary

60 Degrees Pharmaceuticals beats CERo Therapeutics on 2 of the 2 factors compared between the two stocks.

How does CERo Therapeutics compare to Alpha Tau Medical?

CERo Therapeutics (NASDAQ:CEROW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, CERo Therapeutics' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
CERo Therapeutics Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
CERo TherapeuticsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CERo TherapeuticsN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

CERo Therapeutics and Alpha Tau Medical tied by winning 0 of the 0 factors compared between the two stocks.

How does CERo Therapeutics compare to Apollomics?

Apollomics (NASDAQ:APLMW) and CERo Therapeutics (NASDAQ:CEROW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

In the previous week, Apollomics' average media sentiment score of 0.00 equaled CERo Therapeutics'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
CERo Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
CERo Therapeutics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
CERo TherapeuticsN/AN/AN/AN/AN/A

Summary

Apollomics beats CERo Therapeutics on 1 of the 1 factors compared between the two stocks.

How does CERo Therapeutics compare to BioVie?

BioVie (NASDAQ:BIVIW) and CERo Therapeutics (NASDAQ:CEROW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
CERo TherapeuticsN/AN/AN/AN/AN/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled CERo Therapeutics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
CERo Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
CERo Therapeutics N/A N/A N/A

Summary

BioVie and CERo Therapeutics tied by winning 0 of the 0 factors compared between the two stocks.

How does CERo Therapeutics compare to Cardio Diagnostics?

CERo Therapeutics (NASDAQ:CEROW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
CERo TherapeuticsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CERo TherapeuticsN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

In the previous week, CERo Therapeutics' average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
CERo Therapeutics Neutral
Cardio Diagnostics Neutral

Summary

Cardio Diagnostics beats CERo Therapeutics on 1 of the 1 factors compared between the two stocks.

Get CERo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CEROW vs. The Competition

MetricCERo TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$452.84M$6.47B$12.46B
Dividend YieldN/A3.87%2.67%5.34%
P/E RatioN/A3.2023.6923.63
Price / SalesN/A6,606.57520.34114.17
Price / CashN/A13.1342.3557.17
Price / BookN/A83.479.736.37
Net IncomeN/A-$96.07M$3.56B$337.36M
7 Day PerformanceN/A-1.96%-2.92%-2.38%
1 Month PerformanceN/A1.01%-0.85%-0.57%
1 Year PerformanceN/A64.65%22.23%25.53%

CERo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CEROW
CERo Therapeutics
N/A$0.01
+100.0%
N/A-8.2%$0.00N/AN/A8
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-1.8%
N/A-23.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.44
+27.1%
N/A+805.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+5.2%
N/A-37.6%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.32
-3.9%
N/AN/A$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:CEROW) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners